ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Trade (domestic/foreign) TRD

Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines

Contacted: Food & Drug Administration (FDA); Commerce, Dept of (DOC); Federal Trade Commission (FTC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); SENATE

Copyright/Patent/Trademark CPT

Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R.5 Help Efficient, Accessible, Low-cost, Timely Healthcare (Health) Act of 2011 H.R.2182 Generating Antibiotic Incentives Now Act of 2011 S.23 and H.R.1249 America Invents Act, Sections 10 and 11 (Supplemental Examination) S.27 Preserve Access to Affordable Generics Act S.373 Fair Prescription Drug Competition Act

Contacted: Federal Trade Commission (FTC); Commerce, Dept of (DOC); Food & Drug Administration (FDA); White House Office; Patent & Trademark Office (PTO); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Office of Management & Budget (OMB)

Bills named: S. 27 (112th), H.R. 5 (112th), S. 373 (112th), H.R. 2182 (112th), H.R. 1249 (112th), S. 23 (112th)

Medicare/Medicaid MMM

FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs S. 44 - Medicare Prescription Drug Negotiation Act

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Federal Trade Commission (FTC); Congressional Budget Office (CBO); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC)

Bills named: S. 44 (112th)

Budget/Appropriations BUD

Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY11 and FY12 Budget

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); SENATE; Food & Drug Administration (FDA); White House Office; Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Congressional Budget Office (CBO)

Pharmacy PHA

FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug User Fees, Authorized Generics, Prescription Drug Importation/Re-Importation, and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act

Contacted: Federal Trade Commission (FTC); Congressional Budget Office (CBO); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); White House Office; Office of Management & Budget (OMB)

Bills named: S. 296 (112th), S. 373 (112th), H.R. 2182 (112th), H.R. 2245 (112th), S. 44 (112th)